Treatment intensification with an insulin degludec (IDeg)/insulin aspart (IAsp) co‐formulation twice daily compared with basal IDeg and prandial IAsp in type 2 diabetes: a randomized, controlled phase III trial

AIMS: To evaluate the efficacy and safety of two insulin intensification strategies for patients with type 2 diabetes previously treated with basal insulin – insulin degludec (IDeg) and insulin aspart (IAsp) – administered as a co‐formulation (IDegAsp) or as a basal‐bolus regimen (IDeg and IAsp in s...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodbard, H. W., Cariou, B., Pieber, T. R., Endahl, L. A., Zacho, J., Cooper, J. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066701/
https://www.ncbi.nlm.nih.gov/pubmed/26592732
http://dx.doi.org/10.1111/dom.12609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066701/
https://www.ncbi.nlm.nih.gov/pubmed/26592732
http://dx.doi.org/10.1111/dom.12609

Ejemplares similares